Qure stock rallies 110% on reaching alignment with the FDA on key elements of an accelerated approval pathway for AMT-130 to ...

It was a busy week in the biotech sector with lots of data readouts. This apart, the key regulatory updates and pipeline news also continued to be in the spotlight.

GSK, Gilead and Arcellx, Vertex and more present new data at the American Society of Hematology annual meeting just as sickle cell therapies Casgevy and Lyfgenia have a new outcomes-based payment ...

Crucially for the Netherlands-based biopharma company, the FDA has said that the composite Unified Huntington's Disease ...

New, innovative technology is coming to SH 130. The Autonomy Institute says the intelligent infrastructure will focus on traffic control, security and public safety using drones.

Soon, autonomous drones will provide around-the-clock security, inspections, traffic monitoring, and assistance for emergency ...